Universal Technical Institute reported fiscal 2025 revenue of $835.6 million, a 14% year‑over‑year increase that exceeded the company’s twice‑raised guidance range. Adjusted EBITDA reached $126.5 million, comfortably above the $114–$119 million guidance, while net income climbed to $63.0 million. The results reflected strong demand across the company’s transportation, skilled‑trade, and healthcare training programs, confirming the resilience of its blended‑learning model.
Segment‑level data show that UTI’s core transportation and skilled‑trade programs generated $144.6 million in revenue, while Concorde’s healthcare training contributed $77.8 million. Both segments posted growth rates above the company’s historical averages, driven by higher enrollment in high‑margin specialty courses and a continued shift toward online and hybrid delivery formats. The combined segment performance lifted overall revenue and helped offset modest cost increases in support services.
Margin analysis indicates that adjusted EBITDA margin expanded to 15.1% from 14.8% in FY 2024, driven by higher revenue mix and disciplined cost control. Capital expenditures for the first nine months of the year totaled $25.5 million, with a full‑year forecast of $55 million earmarked for campus and program expansion. Management noted that the $40 million of growth investments planned for FY 2026 will temporarily moderate margins, but the company expects the investments to accelerate revenue and margin growth in the long term.
For fiscal 2026, UTI reiterated revenue guidance of $905–$915 million and adjusted EBITDA guidance of $114–$119 million. The guidance reflects confidence in sustained demand and the scalability of the North Star strategy, while acknowledging that the planned capital outlay will create short‑term margin pressure. The company’s outlook signals a focus on expanding its footprint in both the UTI and Concorde brands, particularly after the Department of Education lifted growth restrictions on Concorde Career Colleges.
Looking ahead, UTI targets $1 billion in annual revenue and $200 million in adjusted EBITDA by fiscal 2029. The company attributes this trajectory to accelerated campus expansion, a broadened program portfolio, and the continued adoption of its blended‑learning platform. The lifting of regulatory constraints on Concorde is expected to unlock additional growth opportunities starting in fiscal 2026, positioning the company for a higher‑growth phase.
Analysts noted that UTI’s fiscal 2025 earnings beat expectations, with EPS of $0.34 surpassing the consensus of $0.26 by $0.08 (a 30.8% beat) and revenue of $222.4 million exceeding the estimate of $219.6 million by $2.8 million (a 1.3% beat). The company’s ability to deliver consistent beats on both revenue and earnings, coupled with a clear growth strategy, reinforced positive analyst sentiment.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.